2m 2m 2m 2m 2m 2m 2m
GRIFOLS SP ADR-B (GRFS)
NASDAQ
$7.58-$0.05 (-0.66%)
Price as of Jun 03, 2026 5:31 PM EDT- $5.3BMarket Cap
- -6.97%1-Year Change
- Drug Manufacturers - GeneralIndustry
GRIFOLS SP ADR-B (GRFS)
$7.58-$0.05 (-0.66%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 7.5B +4.32% | 7.2B +9.41% | 6.6B +8.71% | 6.1B +22.92% | |
Cost of Revenue | 4.7B +5.59% | 4.4B +7.82% | 4.1B +6.91% | 3.8B +29.02% | |
Gross Profit | 2.9B +2.31% | 2.8B +12.02% | 2.5B +11.79% | 2.2B +13.70% | |
Sales and Marketing Expense | 81.0M -3.46% | 83.9M +6.40% | 78.9M -93.38% | 1.2B +12.14% | |
Research and Development Expense | -426.0M +10.93% | -384.0M -2.85% | -395.3M +9.45% | -361.1M +1.76% | |
Depreciation and Amortization Expense | 450.0M +2.76% | 437.9M -0.91% | 441.9M +8.35% | 407.9M +13.37% | |
Total Operating Expenses | 1.2B -5.76% | 1.3B -8.15% | 1.4B +14.81% | 1.2B +12.14% | |
Operating Profit | 1.2B +4.28% | 1.2B +49.11% | 799.4M -0.78% | 805.7M +35.39% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 1.0M N/A | 0 -100.00% | 3.0M -86.32% | 22.2M +36.39% | |
Income before Taxes | 500.0M +134.96% | 212.8M +17.79% | 180.7M -33.37% | 271.1M +2.19% | |
Income Taxes | 115.0M -50.26% | 231.2M +433.32% | 43.3M -51.89% | 90.1M +5.86% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 500.0M +134.96% | 212.8M +17.79% | 180.7M -33.37% | 271.1M +2.19% | |
Net Income from Continuing Operations Applicable to Common | 500.0M +134.96% | 212.8M +17.79% | 180.7M -33.37% | 271.1M +2.19% | |
Basic EPS and Net Income | 0.59 +156.52% | 0.23 +155.56% | 0.09 -70.97% | 0.31 +10.71% | |
Diluted EPS and Net Income | 0.59 +156.52% | 0.23 +155.56% | 0.09 -70.97% | 0.31 +10.71% | |
Basic Weighted Average Shares | 680.5M +0.12% | 679.7M -0.01% | 679.8M -0.007% | 679.8M -0.26% | |
Diluted Weighted Average Shares | 680.5M +0.12% | 679.7M -0.01% | 679.8M -0.007% | 679.8M -0.26% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 825.0M -15.80% | 979.8M +85.01% | 529.6M -3.36% | 548.0M -16.40% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 825.0M -15.80% | 979.8M +85.01% | 529.6M -3.36% | 548.0M -16.40% | |
Total Current Assets | 5.1B -11.41% | 5.7B -11.23% | 6.5B +38.64% | 4.7B -15.55% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 3.1B -6.64% | 3.3B +2.92% | 3.2B -0.73% | 3.3B +28.40% | |
Total Long-Term Assets | 14.6B -6.63% | 15.7B +4.59% | 15.0B -11.20% | 16.9B +23.00% | |
Total Assets | 19.7B -7.91% | 21.4B -0.17% | 21.4B -0.43% | 21.5B +11.96% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.0B -6.36% | 2.2B -6.89% | 2.3B +18.39% | 2.0B -43.71% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 10.1B -5.19% | 10.6B -4.58% | 11.2B +0.29% | 11.1B +31.72% | |
Total Liabilities | 12.1B -5.39% | 12.8B -4.98% | 13.5B +3.00% | 13.1B +9.73% | |
Retained Earnings | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | 7.6B -11.67% | 8.6B +7.96% | 8.0B -5.74% | 8.5B +15.59% | |
Total Shares Outstanding | 422.4M +0.04% | 422.2M 0.00% | 422.2M 0.00% | 422.2M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 1.0B +16.05% | 902.2M +333.15% | 208.3M +2,016.66% | -10.9M -101.82% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -579.0M -165.30% | 886.7M +322.98% | -397.6M -79.91% | -2.0B +131.67% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -529.0M -61.07% | -1.4B -830.31% | 186.0M +207.23% | -173.5M -107.55% | |
Financials Ratio | |||||
Gross Margin | 38.00% -1.93% | 38.75% +2.39% | 37.84% +2.83% | 36.80% -7.50% | |
Operating Margin | 16.52% -0.04% | 16.53% +36.29% | 12.13% -8.73% | 13.29% +10.15% | |
Return on Assets | 2.43% +144.85% | 0.99% +18.14% | 0.84% -36.79% | 1.33% -13.49% | |
Return on Equity | 6.17% +140.31% | 2.57% +16.72% | 2.20% -36.02% | 3.44% -9.07% | |
Revenue Growth | 4.32% -54.09% | 9.41% +8.09% | 8.71% -62.02% | 22.92% +400.83% | |
Current Ratio | 2.51 -5.39% | 2.66 -4.66% | 2.79 +17.11% | 2.38 +50.02% | |
Cash Ratio | 0.41 -10.08% | 0.45 +98.69% | 0.23 -18.38% | 0.28 +48.49% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow